                         SEQUENCE LISTING

<110>  APEPTICO Forschung und Entwicklung GmbH
 
<120>  Process for extracorporeal lung treatment

<130>  A 18067

<150>  EP 13164828.9
<151>  2013-04-23

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound having a disulphide bridge


<220>
<221>  DISULFID
<222>  (1)..(17)

<400>  1

Cys Gly Gln Arg Glu Thr Pro Glu Gly Ala Glu Ala Lys Pro Trp Tyr 
1               5                   10                  15      


Cys 
    


<210>  2
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound having an amide bond formed between the amino 
       group attached to the epsilon-C atom of the lysine residue and 
       the side chain carboxyl group attached to the gamma-C of the 
       glutamic acid residue

<400>  2

Lys Ser Pro Gly Gln Arg Glu Thr Pro Glu Gly Ala Glu Ala Lys Pro 
1               5                   10                  15      


Trp Tyr Glu 
            


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound having an amide bond formed between the amino 
       group attached to the epsilon-C atom of the side chain of the 
       lysine residue and the carboxyl group of the glycine residue

<400>  3

Lys Gly Gln Arg Glu Thr Pro Glu Gly Ala Glu Ala Lys Pro Trp Tyr 
1               5                   10                  15      


Gly 
    


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound having an amide bond formed between the amino 
       group attached to the delta-C of the side chain of the ornithine 
       residue and the carboxyl group of the glycine residue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X = ornithine

<400>  4

Xaa Gly Gln Arg Glu Thr Pro Glu Gly Ala Glu Ala Lys Pro Trp Tyr 
1               5                   10                  15      


Gly 
    


<210>  5
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound having an amide bond formed between the amino 
       group of the 4-aminobutanoic acid residue and the side chain 
       carboxyl group attached to the beta-C of the aspartic acid 
       residue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X = 4-aminobutanoic acid

<400>  5

Xaa Gly Gln Arg Glu Thr Pro Glu Gly Ala Glu Ala Lys Pro Trp Tyr 
1               5                   10                  15      


Asp 
    


<210>  6
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound having an amide bond formed between the amino 
       group of the beta-alanine residue and the side chain carboxyl 
       group attached to the gamma-C of the glutamic acid residue


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X = beta-alanine

<400>  6

Xaa Gly Gln Arg Glu Thr Pro Glu Gly Ala Glu Ala Lys Pro Trp Tyr 
1               5                   10                  15      


Glu 
    


<210>  7
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound having a disulphide bridge


<220>
<221>  DISULFID
<222>  (1)..(17)

<400>  7

Cys Gly Gln Arg Glu Ala Pro Ala Gly Ala Ala Ala Lys Pro Trp Tyr 
1               5                   10                  15      


Cys 
    


<210>  8
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  cyclized compound of formula I


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  X = selected from Cys; Lys-Ser-Pro; Lys; ornithine, 4-amino 
       butanoic acid; beta-alanine

<220>
<221>  MOD_RES
<222>  (17)..(17)
<223>  X = selected from Cys; Asp; Gly; Glu

<400>  8

Xaa Gly Gln Arg Glu Thr Pro Glu Gly Ala Glu Ala Lys Pro Trp Tyr 
1               5                   10                  15      


Xaa 
    


